Aclaris Therapeutics Inc. | Key People and Executives
Neal S. Walker
President, Chief Executive Officer & Director
Stephen A. Tullman
Chairman
Bryan M. Reasons
Independent Director
Andrew N. Schiff
Independent Director
Andrew Kenneth William Powell
Independent Director
William D. Humphries
Independent Director
Anand Mehra
Independent Director
Christopher P. Molineaux
Independent Director
Neal S. Walker
President, Chief Executive Officer & Director
Frank Ruffo
Chief Financial Officer
Ben R. Bronstein
Executive Vice President-Clinical Development
Joseph B. Monahan
Executive Vice President-Research & Development
David Gordon
Chief Medical Officer
Stuart D. Shanler
Chief Scientific Officer
Erika Dunbar Senior
Director-Marketing
John Bagdasarian
Vice President-Professional Relations
Elaine Morefield
Director-Product Quality
Brett Fair
Chief Commercial Officer
Kamil Ali-Jackson
Chief Legal Officer
Christopher V. Powala
Chief Regulatory & Development Officer
Michael Stephen Tung
Investor Relations Contact
Sheila Kennedy
Vice President-Communications
Stephen A. Tullman
Chairman
Bryan M. Reasons
Independent Director
Andrew N. Schiff
Independent Director
Andrew Kenneth William Powell
Independent Director
William D. Humphries
Independent Director
Anand Mehra
Independent Director
Christopher P. Molineaux
Independent Director
| Address |
640 Lee Road
Malvern Pennsylvania 19087
United States
|
|
Employees
|
- |
| Website |
http://www.aclaristx.com |
| Updated |
07/08/2019 |
| Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address unmet needs in medical and aesthetic dermatology and immunology. It operates thrpough Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. |
